[{"id":"pdgfra","kind":"target","name":"PDGFRA","route":"/targets/pdgfra/","commit":"0bdbdae6c6","date":"2026-09-09","author":"Jude Gomila","message":"Editing pass: every TL;DR and summary stands alone","file":"src/data/gap-fill.ts","type":"changed","fields":[{"field":"tldr","before":"\"A growth-factor receptor mutated in about 10% of GISTs, including the D842V mutation that resists imatinib but responds to avapritinib.\"","after":"\"PDGFRA is a growth-factor receptor mutated in about 10% of GISTs, including the D842V mutation that resists imatinib but responds to avapritinib.\""}]},{"id":"pdgfra","kind":"target","name":"PDGFRA","route":"/targets/pdgfra/","commit":"71e4eef6e1","date":"2026-09-08","author":"Jude Gomila","message":"Gap audit and gap-fill data: 33 cancers, 87 products, 20 targets, 25 technologies, 12 terms, 18 collections","file":"src/data/gap-fill.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"symbol"},{"field":"targetClass"},{"field":"wikipedia"},{"field":"tldr"},{"field":"summary"},{"field":"biology"},{"field":"whereFound"},{"field":"prevalence"},{"field":"cancers"},{"field":"drugs"},{"field":"technologies"},{"field":"pathways"},{"field":"related"},{"field":"links"},{"field":"tags"}]}]